Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07414199
The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department (ED-Heme FCM)
Sponsor: Children's Hospital of Orange County
Conditions
Iron Deficiency Anaemia Due to Dietary Causes Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease Iron Deficiency Anemia Secondary to IBD or Gastric Bypass Iron Deficiency Anemia Treatment Iron Deficiency Anemias
Interventions
Ferric Carboxymaltose (FCM) Ferrous Sulfate
Updated 1 time since 2026 Last updated: Feb 10, 2026 Started: Jan 31, 2026 Primary completion: Jun 30, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07414199, this PHASE4 trial focuses on Iron Deficiency Anaemia Due to Dietary Causes and Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease and remains actively recruiting participants. Sponsored by Children's Hospital of Orange County, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Children's Hospital of Orange County
Data source: Children's Hospital of Orange County
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.